Champions Oncology Q2 Adj. EPS $0.06 Beats $0.01 Estimate, Sales $15.035M Beat $14.042M Estimate

Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.01 by 500 percent. This is a 20 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $15.035 million which beat the analyst consensus estimate of $14.042 million by 7.07 percent. This is a 11.46 percent increase over sales of $13.489 million the same period last year.